MARIZYME, INC. (MRZM)
Marizyme, Inc. is a medical technology company, which engages in the acquisition, development, and commercialization of therapies that minimize mortality and costs in the acute care space. It offers DuraGraft, a one-time intraoperative vascular graft treatment that improves clinical outcomes by reducing the incidence and complications of graft failure, and Krillase, a patented protease-based therapeutic. The company was founded on March 20, 2007 and is headquartered in Jupiter, FL.
Address
555 HERITAGE DRIVE
JUPITER, FL 33458
Founded
2007
Number of Employees
13
Website
http://www.marizyme.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)